tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Leland Gershell, 177 are a BUY (92.19%), 6 are a SELL (3.13%), 9 are a HOLD (4.69%).
Analyst Leland Gershell, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 35.51% that have a potential upside of 39.66% achieved within 150 days.
Leland Gershell’s has documented 404 price targets and ratings displayed on 44 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 09-May-2025.
Analyst best performing recommendations are on CAPR (CAPRICOR THERAPEUTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 9/23/2024. The price target of $15 was fulfilled within 7 days with a profit of $9.03 (151.26%) receiving and performance score of 216.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$8.63 (256.08%)
$12
8 months 9 days ago
(26-Sep-2024)
0/2 (0%)
$8.93 (290.88%)
Buy
$2.5
$-0.28 (-10.07%)
2 years 3 months 21 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy
$30
2 years 11 months 13 days ago
(22-Jun-2022)
0/2 (0%)
$22.32 (290.63%)
Buy
4 years 9 months 4 days ago
(31-Aug-2020)
0/1 (0%)
$59.52 (163.16%)
Which stock is Leland Gershell is most bullish on?
Which stock is Leland Gershell is most reserved on?
What Year was the first public recommendation made by Leland Gershell?
